HCG18 can increase the expression levels of WIPF1 and DNAJB12 and activate the PI3K/AKT axis in gastric cancer cells, thus promoting gastric cancer progression (Liu et al., 2020a; Ma et al., 2020; Niu et al., 2020). Here, WIPF1 is linked to gastric cancer.